Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival (Q44332051)
Jump to navigation
Jump to search
scientific article published on 10 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival |
scientific article published on 10 May 2012 |
Statements
1 reference
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival (English)
1 reference
Yu Sawada
1 reference
Toshiaki Yoshikawa
1 reference
Daisuke Nobuoka
1 reference
Hirofumi Shirakawa
1 reference
Toshimitsu Kuronuma
1 reference
Yutaka Motomura
1 reference
Shoichi Mizuno
1 reference
Hiroshi Ishii
1 reference
Kohei Nakachi
1 reference
Masaru Konishi
1 reference
Toshio Nakagohri
1 reference
Shinichiro Takahashi
1 reference
Naoto Gotohda
1 reference
Tadatoshi Takayama
1 reference
Kenji Yamao
1 reference
Katsuhiko Uesaka
1 reference
Junji Furuse
1 reference
Taira Kinoshita
1 reference
Tetsuya Nakatsura
1 reference
10 May 2012
1 reference
1 reference
Identifiers
1 reference